152126-31-3Relevant articles and documents
The discovery of potent small molecule cyclic urea activators of STING
Banerjee, Monali,Basu, Sourav,Ghosh, Rajib,Middya, Sandip,Pryde, David C.,Shrivastava, Ritesh,Surya, Arjun,Yadav, Dharmendra B.
supporting information, (2022/02/07)
STING mediates innate immune responses that are triggered by the presence of cytosolic DNA. Activation of STING to boost antigen recognition is a therapeutic modality that is currently being tested in cancer patients using nucleic-acid based macrocyclic STING ligands. We describe here the discovery of 3,4-dihydroquinazolin-2(1H)-one based 6,6-bicyclic heterocyclic agonists of human STING that activate all known human variants of STING with high potency.
SPECIFIC CARBOXAMIDES AS KCNQ2/3 MODULATORS
-
Page/Page column 38, (2014/06/23)
The invention relates to specific carboxamides of formula (I) as KCNQ2/3 modulators, to processes for their preparation, to medicaments comprising these compounds and to the use of these compounds in the preparation of medicaments.
Reactivity of 1-(des-3-hydroxy-picolinoyl) pristinamycin I(A)
Barriere, Jean-Claude,Bacque, Eric,Puchault, Gerard,Quenet, Yves,Molherat, Christian,Cassayre, Jerome,Paris, Jean-Marc
, p. 12859 - 12886 (2007/10/03)
1-(Des-3-hydroxy-picolinoyl) pristinamycin I(A) (PI-NH2) was shown to undergo a variety of reactions, including two unexpected transformations, to afford new pristinamycin I(A) derivatives.